معرفی
Natalia McInnes serves as Associate Professor in the Department of Medicine within McMaster University's Faculty of Health Sciences, where she leads groundbreaking research in diabetes remission strategies. Her work challenges traditional views of Type 2 diabetes as an inevitably progressive condition by demonstrating how intensive metabolic interventions can induce sustained remission.
Dr. McInnes's research focuses on several critical areas in diabetes therapeutics:
- Mechanisms of beta-cell function preservation and recovery
- Glycemic thresholds that optimize therapeutic responses
- Combination therapies using insulin glargine, GLP-1 receptor agonists, and lifestyle modifications
- Diabetes health coaching interventions for community-based care
Her scholarly output reveals a consistent trajectory toward understanding remission mechanisms and developing practical clinical protocols. Recent publications (2023-2025) increasingly focus on long-term maintenance of remission, relapse predictors, and economic analyses of intervention strategies, indicating maturation of her research program from proof-of-concept studies to implementation science.
Dr. McInnes's work has achieved significant real-world impact, with findings referenced in clinical practice guidelines, policy documents, and multiple news outlets. Her leadership in trials like REMIT-iGlarLixi and RESET-IT Main has positioned her as a key contributor to the paradigm shift in diabetes management toward remission as a treatment goal.
Her collaborative approach is evident through multicenter trial designs and diverse publication venues spanning basic science journals like Nature Communications to clinical journals like Diabetes Care and implementation-focused publications in the Canadian Journal of Diabetes.
